APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COM NEW
Total 13F shares
867,109
Share change
+72,581
Total reported value
$2,635,000
Price per share
$3.04
Number of holders
20
Value change
+$169,943
Number of buys
10
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q3 2022

As of 30 Sep 2022, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 867,109 shares. The largest 10 holders included VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, CANTOR FITZGERALD, L. P., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Virtu Financial LLC, Bank of New York Mellon Corp, and MORGAN STANLEY. This page lists 20 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.